Key statistics
On Friday, Tandem Diabetes Care Inc (0M0F:LSE) closed at 44.26, -18.04% below its 52-week high of 54.00, set on May 31, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 44.26 |
Low | 44.26 |
Bid | -- |
Offer | -- |
Previous close | 44.41 |
Average volume | 684.20 |
---|---|
Shares outstanding | 65.46m |
Free float | 64.97m |
P/E (TTM) | -- |
Market cap | 2.92bn USD |
EPS (TTM) | -2.09 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 18:32 BST.
More ▼
Press releases
- Tandem t:slim X2 Insulin Pump Now Compatible with Lyumjev Ultra-rapid Acting Insulin in European Union
- Tandem Diabetes Care Announces Upcoming Conference Participation
- Tandem Diabetes Care to Release Updated iOS t:connect Mobile App for t:slim X2 Insulin Pump Users Impacted by March 2024 Nationwide Recall
- Tandem Diabetes Care Provides Update on March 2024 Nationwide Recall of t:connect Mobile App for iOS Devices
- Tandem Diabetes Care Announces Second Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance
- Tandem Diabetes Care Announces Upcoming Conference Presentation
- Tandem Diabetes Care and Dexcom Announce the t:slim X2 Insulin Pump with Dexcom G7 CGM Compatibility is Authorized for Sale by Health Canada
- Tandem Diabetes Care to Announce Second Quarter 2024 Financial Results on August 1, 2024
More ▼